annb0t
Top 20
Teleflexâs TFX innovative product launches across the business units are highly encouraging. Expansion efforts in Asian countries should contribute to its growth. However, macroeconomic concerns weigh on the stock. Teleflex carries a Zacks Rank #3 (Hold) currently.
Teleflexâs prime-line UroLift System has been successfully gaining market share as a minimally invasive technology in treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). In 2023, more than 450,0...
>>> Read more: Teleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay
Teleflexâs prime-line UroLift System has been successfully gaining market share as a minimally invasive technology in treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). In 2023, more than 450,0...
>>> Read more: Teleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay
